| NCT Number | NCT05914779 |
| Lead Sponsor | Hamad Medical Corporation |
| Conditions | Infection, Bacterial, Out-Of-Hospital Cardiac Arrest |
| Enrollment | 1,000 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2025-12-31 (estimated) |
| Study Completion | 2025-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-04-03 |